Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma

Comprehensive Analysis of the Prognostic Value and Immune Function of Immune Checkpoints in Stomach Adenocarcinoma

Kai Shen, Tong Liu Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Tong LiuDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaEmail tongliu2021...

Full description

Bibliographic Details
Main Authors:	Shen K, Liu T
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-09-01
Series:	International Journal of General Medicine
Subjects:	stomach adenocarcinoma bioinformatics analysis cancer immunotherapy immune checkpoint
Online Access:	https://www.dovepress.com/comprehensive-analysis-of-the-prognostic-value-and-immune-function-of--peer-reviewed-fulltext-article-IJGM

Similar Items

Immune Checkpoint-Mediated Interactions Between Cancer and Immune Cells in Prostate Adenocarcinoma and Melanoma
by: Angela Rita Elia, et al.
Published: (2018-07-01)

New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors
by: YANG Changliang, et al.
Published: (2018-12-01)

Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer
by: Ma R, et al.
Published: (2021-05-01)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
by: Dina Guo, et al.
Published: (2020-03-01)

Prognostic Value and Biological Functions of RNA Binding Proteins in Stomach Adenocarcinoma
by: Li J, et al.
Published: (2021-03-01)

Advances of immune checkpoints in colorectal cancer treatment
by: Qinlian Jiao, et al.
Published: (2020-03-01)

Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability
by: Dongdong Yang, et al.
Published: (2021-02-01)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
by: Li W, et al.
Published: (2020-11-01)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
by: François Bertucci, et al.
Published: (2021-01-01)

Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
by: Xing Huang, et al.
Published: (2020-08-01)

HLA-G: A New Immune Checkpoint in Cancer?
by: Daniëlle Krijgsman, et al.
Published: (2020-06-01)

Research Progress of Immune Checkpoint Therapy on Colorectal Cancer
by: CAO Qihua, et al.
Published: (2021-03-01)

Immune Checkpoints in Cancers: From Signaling to the Clinic
by: Céline Pisibon, et al.
Published: (2021-09-01)

A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma
by: Songling Han, et al.
Published: (2021-08-01)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
by: Lisa K. Puntigam, et al.
Published: (2020-07-01)

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
by: Matthew P. Humphries, et al.
Published: (2020-06-01)

Advances of immune checkpoint blockade in the treatment of advanced gastric cancer
by: Zhi-Jia Sun, et al.
Published: (2017-06-01)

Soluble immune checkpoints in cancer: production, function and biological significance
by: Daqian Gu, et al.
Published: (2018-11-01)

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
by: Noelia Vilariño, et al.
Published: (2020-08-01)

Immune checkpoint inhibitors in the treatment of virus-associated cancers
by: Peipei Gao, et al.
Published: (2019-06-01)

Control of NK Cell Activation by Immune Checkpoint Molecules
by: Asma Beldi-Ferchiou, et al.
Published: (2017-10-01)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
by: Yulia Kundel, et al.
Published: (2020-10-01)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
by: Florencia Veigas, et al.
Published: (2021-03-01)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
by: Yang Wen, et al.
Published: (2021-06-01)

Immune Checkpoints in Viral Infections
by: Huiming Cai, et al.
Published: (2020-09-01)

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy
by: Robert J. Torphy, et al.
Published: (2017-12-01)

Immune Checkpoint Inhibition in Oesophago-Gastric Carcinoma
by: Anica Högner, et al.
Published: (2021-02-01)

NK Cell-Based Immune Checkpoint Inhibition
by: Muhammad Khan, et al.
Published: (2020-02-01)

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
by: Negar Hosseinkhani, et al.
Published: (2020-11-01)

Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
by: Hiromichi Nakajima, et al.
Published: (2021-01-01)

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
by: Lara Gibellini, et al.
Published: (2020-03-01)

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
by: Amina Ghouzlani, et al.
Published: (2021-07-01)

Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors
by: Ho Jung An, et al.
Published: (2021-08-01)

An individualized immune prognostic signature in lung adenocarcinoma
by: Liangdong Sun, et al.
Published: (2020-05-01)

An overview of immune checkpoint inhibitors in breast cancer
by: Federica Miglietta, et al.
Published: (2020-12-01)

Inhibitory Receptors and Immune Checkpoints Regulating Natural Killer Cell Responses to Cancer
by: Irina Buckle, et al.
Published: (2021-08-01)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
by: Stephanie Sanders, et al.
Published: (2020-04-01)

Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01)

Premature clinical trial discontinuation in the era of immune checkpoint inhibitors
by: Khunger, Monica, et al.
Published: (2018)

Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
by: Alexandre Perrier, et al.
Published: (2020-07-01)